![Robert Lenk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Lenk
President bij
Lenk Pharmaceuticals, LLC
Vermogen: 32 435 $ op 31-05-2026
Profiel
Robert P.
Lenk was the founder of The Liposome Co., Inc., founded in 1981, and Argus Pharmaceuticals, Inc., founded in 1989, where the title held was Vice President-Research & Development.
Current jobs include Director at POP Biotechnologies, Inc., Partner at Houston Partners Private Equity Group LLC, and President at Lenk Pharmaceuticals, LLC since 2016.
Former jobs include President & Chief Executive Officer at Therapeutics 2000, Inc. from 1995 to 2003, Independent Non-Executive Director at Plus Therapeutics, Inc. from 2020 to 2026, President-Luna Nanoworks Division at Luna Innovations, Inc. from 2004 to 2010, President at OncoVector, Inc., and Chief Scientific Officer at MediVector, Inc. from 2010 to 2016.
Education includes undergraduate and doctorate degrees from the Massachusetts Institute of Technology.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-03-2026 | 5.573 ( 0,08% ) | 32 435 $ | 31-05-2026 |
Actieve functies van Robert Lenk
| Bedrijven | Functie | Begin |
|---|---|---|
Houston Partners
 Houston Partners Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | - |
Lenk Pharmaceuticals, LLC | President | 01-01-2016 |
POP Biotechnologies, Inc.
 POP Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Bestuurslid | - |
Eerdere bekende functies van Robert Lenk
| Bedrijven | Functie | Einde |
|---|---|---|
| PLUS THERAPEUTICS, INC. | Directeur/Bestuurslid | 20-03-2026 |
MediVector, Inc.
 MediVector, Inc. Medical/Nursing ServicesHealth Services MediVector, Inc. is a private company based in Cambridge, MA and has subsidiaries in the United States. | Hoofd Techniek/Wetenschap/O&O | 01-01-2016 |
| LUNA INNOVATIONS INCORPORATED | Corporate Officer/Principal | 15-04-2010 |
Therapeutics 2000, Inc. | Algemeen Directeur | 01-09-2003 |
Argus Pharmaceuticals, Inc.
 Argus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Oprichter | - |
Opleiding van Robert Lenk
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
20
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
The Liposome Co., Inc.
 The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets therapeutic products to treat cancer and related diseases | Health Technology |
Luna Innovations, Inc.
 Luna Innovations, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops and distributes fiber optic test, measurement and control products | Electronic Technology |
Argus Pharmaceuticals, Inc.
Argus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Houston Partners
Houston Partners Investment ManagersFinance Acts as an alternative investment manager | Finance |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
MediVector, Inc.
MediVector, Inc. Medical/Nursing ServicesHealth Services MediVector, Inc. is a private company based in Cambridge, MA and has subsidiaries in the United States. | Health Services |
OncoVector, Inc. | |
Therapeutics 2000, Inc. | |
Lenk Pharmaceuticals, LLC | |
POP Biotechnologies, Inc.
POP Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
